Works by Reinthaller, Alexander

Results: 66
    1

    CD44 is an independent prognostic factor in early-stage cervical cancer.

    Published in:
    International Journal of Cancer, 1997, v. 74, n. 2, p. 185, doi. 10.1002/(SICI)1097-0215(19970422)74:2<185::AID-IJC8>3.0.CO;2-V
    By:
    • Speiser, Paul;
    • Wanner, Christian;
    • Tempfer, Clemens;
    • Mittelböck, Maria;
    • Hanzal, Engelbert;
    • Bancher-Todesca, Dagmar;
    • Gitsch, Gerald;
    • Reinthaller, Alexander;
    • Kainz, Christian
    Publication type:
    Article
    2
    3

    Distinctive outcome in patients with non-uterine and uterine leiomyosarcoma.

    Published in:
    BMC Cancer, 2014, v. 14, n. 1, p. 1, doi. 10.1186/1471-2407-14-981
    By:
    • Lamm, Wolfgang;
    • Natter, Camilla;
    • Schur, Sophie;
    • Köstler, Wolfgang J.;
    • Reinthaller, Alexander;
    • Krainer, Michael;
    • Grimm, Christoph;
    • Horvath, Reinhard;
    • Amann, Gabriele;
    • Funovics, Philipp;
    • Brodowicz, Thomas;
    • Polterauer, Stephan
    Publication type:
    Article
    4
    5
    6
    7
    8
    9
    10
    11
    12
    13

    miR-203 is an independent molecular predictor of prognosis and treatment outcome in ovarian cancer: a multi-institutional study.

    Published in:
    Carcinogenesis, 2020, v. 41, n. 4, p. 442, doi. 10.1093/carcin/bgz163
    By:
    • Panoutsopoulou, Konstantina;
    • Avgeris, Margaritis;
    • Mavridis, Konstantinos;
    • Dreyer, Tobias;
    • Dorn, Julia;
    • Obermayr, Eva;
    • Reinthaller, Alexander;
    • Michaelidou, Kleita;
    • Mahner, Sven;
    • Vergote, Ignace;
    • Vanderstichele, Adriaan;
    • Braicu, Ioana;
    • Sehouli, Jalid;
    • Zeillinger, Robert;
    • Magdolen, Viktor;
    • Scorilas, Andreas
    Publication type:
    Article
    14
    15

    Olaparib plus bevacizumab as maintenance therapy in patients with newly diagnosed, advanced ovarian cancer: Japan subset from the PAOLA-1/ENGOT-ov25 trial.

    Published in:
    Journal of Gynecologic Oncology, 2021, v. 32, n. 5, p. 1, doi. 10.3802/jgo.2021.32.e82
    By:
    • Keiichi Fujiwara;
    • Hiroyuki Fujiwara;
    • Hiroyuki Yoshida;
    • Toyomi Satoh;
    • Kan Yonemori;
    • Shoji Nagao;
    • Takashi Matsumoto;
    • Hiroaki Kobayashi;
    • Bourgeois, Hughes;
    • Harter, Philipp;
    • Mosconi, Anna Maria;
    • Vazquez, Isabel Palacio;
    • Reinthaller, Alexander;
    • Tomoko Fujita;
    • Rowe, Philip;
    • Pujade-Lauraine, Eric;
    • Ray-Coquard, Isabelle
    Publication type:
    Article
    16
    17
    18
    19
    20
    21
    22
    23
    24
    25
    26
    27
    28
    29
    30

    Tumor Growth Rate Estimates Are Independently Predictive of Therapy Response and Survival in Recurrent High-Grade Serous Ovarian Cancer Patients.

    Published in:
    Cancers, 2021, v. 13, n. 5, p. 1076, doi. 10.3390/cancers13051076
    By:
    • Bartl, Thomas;
    • Karacs, Jasmine;
    • Kreuzinger, Caroline;
    • Pfaffinger, Stephanie;
    • Kendler, Jonatan;
    • Ciocsirescu, Cristina;
    • Wolf, Andrea;
    • Reinthaller, Alexander;
    • Meyer, Elias;
    • Brandstetter, Maximilian;
    • Postl, Magdalena;
    • Langthaler, Eva;
    • Braicu, Elena;
    • Vergote, Ignace;
    • Cunnea, Paula;
    • Gourley, Charlie;
    • Schmitt, Wolfgang D.;
    • Cacsire Castillo-Tong, Dan;
    • Christoph, Grimm;
    • Murph, Mandi
    Publication type:
    Article
    31
    32
    33
    34
    35
    36
    37
    38
    39

    miR‐181a overexpression predicts the poor treatment response and early‐progression of serous ovarian cancer patients.

    Published in:
    International Journal of Cancer, 2020, v. 147, n. 12, p. 3560, doi. 10.1002/ijc.33182
    By:
    • Panoutsopoulou, Konstantina;
    • Avgeris, Margaritis;
    • Magkou, Paraskevi;
    • Mavridis, Konstantinos;
    • Dreyer, Tobias;
    • Dorn, Julia;
    • Obermayr, Eva;
    • Reinthaller, Alexander;
    • Michaelidou, Kleita;
    • Mahner, Sven;
    • Vergote, Ignace;
    • Loverix, Liselore;
    • Braicu, Ioana;
    • Sehouli, Jalid;
    • Zeillinger, Robert;
    • Magdolen, Viktor;
    • Scorilas, Andreas
    Publication type:
    Article
    40

    Absence of p53 protein overexpression in precancerous lesions of the vulva.

    Published in:
    1998
    By:
    • Kohlberger, Petra D.;
    • Kirnbauer, Reinhard;
    • Bancher, Dagmar;
    • Gitsch, Gerald;
    • Reinthaller, Alexander;
    • Leodolter, Sepp;
    • Tschachler, Erwin;
    • Kainz, Christian;
    • Breitenecker, Gerhard;
    • Kohlberger, P D;
    • Kirnbauer, R;
    • Bancher, D;
    • Gitsch, G;
    • Reinthaller, A;
    • Leodolter, S;
    • Tschachler, E;
    • Kainz, C;
    • Breitenecker, G
    Publication type:
    journal article
    41
    42
    43
    44
    45
    46
    47
    48

    Clinical consequences of the Calypso trial showing superiority of PEG-liposomal doxorubicin and carboplatin over paclitaxel and carboplatin in recurrent ovarian cancer: Results of an Austrian gynecologic oncologists' expert meeting.

    Published in:
    Wiener Klinische Wochenschrift, 2010, v. 122, n. 21/22, p. 649, doi. 10.1007/s00508-010-1483-1
    By:
    • Petru, Edgar;
    • Reinthaller, Alexander;
    • Angleitner-Boubenizek, Lukas;
    • Schauer, Christian;
    • Zeimet, Alain;
    • Dirschlmayer, Wolfgang;
    • Medl, Michael;
    • Stummvoll, Wolfgang;
    • Sevelda, Paul;
    • Marth, Christian
    Publication type:
    Article
    49
    50